About this trial
The registry for the improvement of postoperative outcomes in cardiac and thoracic surgery aims to prospectively collect data in order to test the association between various preoperative and per-operative variables ; and several postoperative outcomes such as mortality, shock, redo surgery, sepsis and extracorporeal life-support.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
all patients eligible for cardiac or thoracic surgery
Disqualifiers
non applicable
Trial population
All patients undergoing cardiac or thoracic surgery in CMC Ambroise Paré
Trial design
Cohort
Prospective
Treatments tested in this trial
Cardiothoracic surgery
Procedure/SurgeryCardiac or thoracic procedure
Treatment groups
Trial outcomes
Primary outcomes
In-hospital mortality
death occurring in the same hospital where the operation took place before discharge from the hospital
Secondary outcomes
Postoperative shock
Use of catecholamines (dobutamine, norepinephrine and/or epinephrine) in order to achieve adequate cardiac output (cardiac index \> 2.2 l/min/m2), in the first 24 hours after surgery
Length of stay in the ICU (days)
length of stay in the intensive care unit after cardiac or thoracic surgery
Total length of stay (days)
length of stay in the hospital, including preoperative period
Mediastinitis
Incidence of mediastinitis in the postoperative period
Sponsors and contacts
Click on the lead sponsor to view all of their trials.